Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

PHASE4CompletedINTERVENTIONAL
Enrollment

411

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
Interventions
DRUG

Naftopidil

Trial Locations (1)

Unknown

Chonnam national university hospital, Gwangju

All Listed Sponsors
lead

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY

NCT01922375 - Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter